Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 2Thoracic 1Sarcoma 1Head & Neck 1Gastrointestinal 1CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 370Head and Neck Neoplasms 355Nasopharyngeal Carcinoma 140Thyroid Neoplasms 124Carcinoma, Non-Small-Cell Lung 93Mouth Neoplasms 84Melanoma 76Breast Neoplasms 75Oropharyngeal Neoplasms 72Colorectal Neoplasms 68Uterine Cervical Neoplasms 66Lung Neoplasms 66Neoplasms 63Ovarian Neoplasms 61Neoplasm Metastasis 52Prostatic Neoplasms 51Stomach Neoplasms 49Pancreatic Neoplasms 47Carcinoma, Squamous Cell 45Triple Negative Breast Neoplasms 43Esophageal Neoplasms 42Endometrial Neoplasms 42Laryngeal Neoplasms 41Thyroid Nodule 37Carcinoma, Renal Cell 37Urinary Bladder Neoplasms 36Sarcoma 34Recurrence 31Carcinoma 30Nasopharyngeal Neoplasms 28

Interventions

Panitumumab 1IFL protocol 1Gemcitabine 1Cetuximab 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Histiocytosis × Head & Neck × Clear all
NCT05786924 2026-04-21

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Servier

Phase 1/2 Recruiting
554 enrolled
CNSGastrointestinalHead & NeckMyeloidThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Histiocytosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡